Whole-body low-dose CT can be of value in prostate cancer decision-making: a retrospective study on 601 patients

被引：0
作者：
Mohammadreza Chavoshi
Seyed Ali Mirshahvalad
Sara Zamani
Amir Reza Radmard
Babak Fallahi
Seyed Asadollah Mousavi
机构：
[1] Hematology-Oncology and BMT Research Center/Tehran University of Medical Sciences,Department of Hematology
[2] Tehran University of Medical Sciences,Oncology
[3] University of Toronto,Department of Radiology, Shariati Hospital
[4] Tehran University of Medical Sciences,Joint Department of Medical Imaging (JDMI), University Medical Imaging Toronto (UMIT), University Health Network, Mount Sinai Hospital and Women’s College Hospital
[5] Isfahan University of Medical Sciences,Department of Nuclear Medicine, Shariati Hospital
来源：
Insights into Imaging | / 14卷
关键词：
Prostate; Computed tomography; Bone; Metastasis; Ga-PSMA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The whole-body CT showed 81.0%-89.4% sensitivity and 96.6–98.5% specificity in detecting osteo-metastases.The whole-body CT could detect high-burden disease considering CHAARTED and LATITUDE criteria.Regarding CT features, lesions with Hu>900 were found benign with 93% specificity.
引用
收藏
相关论文
共 99 条
  • [1] Azad GK(2016)Molecular and functional imaging of bone metastases in breast and prostate cancers: an overview Clin Nuc Med 41 e44-e50
  • [2] Taylor B(2020)Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 31 1119-1134
  • [3] Rubello D(2015)Chemohormonal therapy in metastatic hormone-sensitive prostate cancer N Engl J Med 373 737-746
  • [4] Colletti PM(2017)Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer N Engl J Med 377 352-360
  • [5] Goh V(2021)Prostate cancer, version 1.2021: Featured updates to the nccn guidelines J Natl Compr Can Netw 19 134-143
  • [6] Cook GJ(2020)Can Ga-68 PSMA PET/CT replace conventional imaging modalities for primary lymph node and bone staging of prostate cancer? Eur Urol Focus 6 218-220
  • [7] Parker C(2018)Metastatic prostate cancer N Engl J Med 378 645-657
  • [8] Gillessen S(2018)Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: additional value of morphologic information from low dose CT Eur Radiol 28 610-619
  • [9] Heidenreich A(2018)68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? Clin Genitourin Cancer 16 392-401
  • [10] Horwich A(2021)68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement Eur J Nucl Med Mol Imaging 65 124-137
12345678910